Skip to main content
Premium Trial:

Request an Annual Quote

Court Denies Illumina Appeal to Reconsider Ruling in Patent Suit Against Complete Genomics

NEW YORK (GenomeWeb News) – In a patent infringement suit between Illumina and Complete Genomics, the US District Court for the Northern District of California this week denied a motion by Illumina to reconsider a judgment the court rendered in favor of Complete Genomics last October.

The October ruling found certain claims of an Illumina patent to be invalid due to prior art.

The dispute between the firms began in 2010, when Illumina sued Complete Genomics, alleging infringement of three of its sequencing-related patents: US Patent No. 6,306,597; 7,232,656; and 7,598,035.

Last year, Judge Elizabeth Laporte of the US District Court for the Northern District of California issued a claims construction order only on the '597 patent. Then, in October, Laporte granted Complete Genomics a partial summary judgment, ruling that Claim 1 and dependent Claims 9, 10, 14, 15, 16, 17, 18, and 19 of the '597 patent were invalid.

After that ruling, Illumina petitioned the court to reconsider its ruling, contending that the court decision was "manifestly unjust."

The court considered Illumina's motion and this week issued its ruling, denying the appeal. In addition, it amended its original order for partial summary judgment "to correct two minor errors that do not affect the merits."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.